Decompressive surgery for treating nerve damage in leprosy. A Cochrane review

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
Leprosy review (Impact Factor: 0.67). 04/2009; 80(1):3-12.
Source: PubMed


Decompressive surgery is used for treating nerve damage in leprosy. We assessed the effectiveness of decompressive surgery for patients with nerve damage due to leprosy.
A broad search strategy was performed to find eligible studies, selecting randomised controlled trials (RCTs) comparing decompressive surgery alone or plus corticosteroids with corticosteroids alone, placebo or no treatment. Two authors independently assessed quality and extracted data. Where it was not possible to perform a meta-analysis, the data for each trial was summarised.
We included two randomised controlled trials involving 88 people. The trials examined the added benefit of surgery over prednisolone for treatment of nerve damage of less than 6 months duration. After 2 years follow-up there was no significant difference in nerve function improvement between people treated with surgery plus prednisolone or with prednisolone alone. Adverse effects of decompression surgery were not adequately described.
Evidence from randomised controlled trials does not show a significant added benefit of surgery over steroid treatment alone. Well-designed randomised controlled trials are needed to establish the effectiveness of the combination of surgery and medical treatment compared to medical treatment alone.

Download full-text


Available from: Ton A R Schreuders, Oct 01, 2015
125 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Leprosy has nearly disappeared in France but continues to affect two million patients in the world. Involvement of the peripheral nerve must be identified and requires surgical treatment, which can provide good results for pain and function. The author reviews the most frequently affected peripheral nerves and reports her personal series, with surgery performed concomitantly with the medical treatment of the disease.
    Neurochirurgie 10/2009; 55(4):421-426. DOI:10.1016/j.neuchi.2009.09.003 · 0.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Leprosy is one of the six diseases that the WHO considers as the major threat in developing countries. Damage to nerves can occur before, during, and after treatment and can result in disabilities and long-term disfigurement, which is associated with stigma. Considered exotic and rare in European countries, it is important for neurologists to be able to make the diagnosis of leprosy early in order to rapidly alleviate patient suffering and prevent and reverse nerve damage. Leprosy must be considered in the differential diagnosis of peripheral neuropathy, even in the absence of skin lesions and especially when present in a patient from an endemic country. Immune response and mechanisms involved in nerve damage are not clearly understood. There is no predictive test for the extent of nerve damage and no good evidence on the best treatment.
    Revue Neurologique 12/2012; 168(12):967–974. DOI:10.1016/j.neurol.2012.05.017 · 0.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Leprosy still affects 240,000 persons every year in the world. It is a particularly common cause of neuropathy and severe disabilities in developing countries. With increasing migration, new cases of leprosy are regularly diagnosed in developed countries, where it still remains rare and so underestimated. Cutaneo-nevritic leprosy is the most frequent form of leprosy. It may be diagnosed by the clinical features and the cutaneous histology and bacteriology. Neuritic leprosy without obvious skin lesions is reported in 5 to 15% of leprosy patients. It must be suspected in persons from areas of endemic disease presenting with nerve thickening and associated nerve deficit. Nerve biopsy is essential for diagnosis. However search for bacilli in cutaneous samples may be of great help and avoid nerve biopsy. Acute and severe neuritis occurs during reactionnal states, reversal reaction (Type 1) and erythema nodosum leprosum (Type 2). Multidrug therapy is advocated. The treatment of acute neuropathy needs a supplementary medical and sometimes surgical treatment.
    Revue Neurologique 12/2012; 168(12):960–966. DOI:10.1016/j.neurol.2012.09.005 · 0.66 Impact Factor
Show more